View in EDS HTML Full Text PDF Full Text

Off-Label Ustekinumab and Vedolizumab in Pediatric Anti-TNFα Refractory IBD: Therapeutic Drug Monitoring Insights from a Case Series.

Saved in:
Bibliographic Details
Title: Off-Label Ustekinumab and Vedolizumab in Pediatric Anti-TNFα Refractory IBD: Therapeutic Drug Monitoring Insights from a Case Series.
Authors: Cheli, Stefania1 (AUTHOR) stefania.cheli@asst-fbf-sacco.it, Mosini, Giulia1,2 (AUTHOR), Battini, Vera1,3 (AUTHOR), Carnovale, Carla1 (AUTHOR), Radice, Sonia1,2 (AUTHOR), Lebiu, Marta2,3 (AUTHOR), Cattoni, Alessandro2 (AUTHOR), Zuin, Giovanna2 (AUTHOR), Clementi, Emilio1,3 (AUTHOR)
Source: Pharmaceuticals (14248247). Jan2026, Vol. 19 Issue 1, p154. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14248247
DOI:10.3390/ph19010154